Astal Laboratories promoter ACESO buys 25,417 shares on BSE
- ACESO Research Labs LLP bought 25,417 Astal Laboratories shares
- Transaction valued at ₹19,99,812 executed on BSE
- Purchase period spanned August 24 to September 8, 2026
- Promoter holding rose to 2,011,012 equity shares
- No derivative trading reported by the promoter

*this image is generated using AI for illustrative purposes only.
Astal Laboratories disclosed a share purchase by its promoter, ACESO Research Labs LLP, under SEBI’s insider trading regulations. The transaction reflects increased promoter confidence in the listed entity.
Transaction Details
ACESO Research Labs LLP acquired 25,417 equity shares of Astal Laboratories Limited on the Bombay Stock Exchange (BSE). The purchase was executed in the open market between August 24, 2026 and September 8, 2026. The total value of the transaction stood at ₹19,99,812, excluding taxes and brokerage charges.
The acquisition increased ACESO’s total holding to 2,011,012 equity shares. Prior to this transaction, the promoter held 1,985,595 shares.
| Metric | Details |
|---|---|
| Promoter Entity | ACESO Research Labs LLP |
| Shares Purchased | 25,417 |
| Transaction Value | ₹19,99,812 |
| Execution Window | August 24, 2026 – September 8, 2026 |
| Exchange | BSE |
| Post-Transaction Holding | 2,011,012 shares |
Regulatory Disclosure
The company filed the disclosure with the BSE on September 11, 2026, pursuant to Regulation 7(2)(b) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. Mahendra Kumar, Company Secretary and Compliance Officer of Astal Laboratories, signed the intimation letter.
Ravikanti Shailaja, Designated Partner of ACESO Research Labs LLP, submitted Form C to the Board of Directors on September 10, 2026. The form confirmed that no derivatives trading occurred in the company’s securities during this period.
Historical Stock Returns for Astal Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.53% | -4.08% | -6.39% | -2.27% | -6.45% | 0.0% |
Will this open-market purchase signal the start of a larger accumulation phase by ACESO Research Labs LLP in the coming quarters?
How might this increase in promoter holding influence Astal Laboratories' stock liquidity and trading volume on the BSE?
Are there any upcoming operational milestones or financial results that could justify the promoter's increased confidence at this specific time?


































